Iovance Biotherapeutics Inc Asset Turnover Ratio (IOVA), as of first quarter 2026, current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Iovance Biotherapeutics inc   (NASDAQ: IOVA)
 

Iovance Biotherapeutics Inc Asset Turnover Ratio

Quarterly Results, Trends, Rankings, Statistics

Iovance Biotherapeutics Inc asset turnover ratio, the ability of Iovance Biotherapeutics Inc 's assets to generate revenue in the first quarter 2026, increased sequentially to 0.31 in the first quarter (Mar 31 2026), a new company high.

Within sector 23 more businesses have achieved higher asset turnover ratio. While Asset turnover ratio total ranking has improved so far during the I Quarter 2026, to 1785, from total ranking in the fourth quarter 2025 at 2372.

Asset Turnover Ratio Definition


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

IOVA Asset Turnover Ratio (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter		 (Mar 31 2025)
I. Quarter
Y / Y Asset Change -4.25 % 6.74 % -2.35 % 1.22 % 20.9 %
Y / Y Revenue Change 44.82 % 17.74 % 15.2 % 92.73 % 6798.46 %
Asset Turnover Ratio (TTM) 0.31 0.29 0.28 0.26 0.23
IOVA's Total Ranking # 1785 # 2372 # 2515 # 2413 # 2476
Seq. Asset Change 1.37 % 0.91 % -0.27 % -6.13 % 13 %
Seq. Revenue Change -17.68 % 28.64 % 12.52 % 21.55 % -33.07 %



Asset Turnover Ratio Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry # 24
Healthcare Sector # 286
Overall Market # 1785

Asset Turnover Ratio Statistics
High Average Low
0.31 0.18 0
(Mar 31 2026)   (Mar 31 2024)




IOVA Company Profile • Back to IOVA Efficiency Comparisons • Compare IOVA Asset Turnover Ratio to its Competitors



Companies with similar Asset Turnover Ratio for the quarter ending Mar 31 2026, within Healthcare Sector Asset Turnover Ratio Revenues for 12 Months ending Mar 31 2026 Assets at quarter ending Mar 31 2026
Adma Biologics Inc   0.84 $ 507.766  Millions$ 604.123  Millions
Bioventus Inc   0.84 $ 575.558  Millions$ 685.620  Millions
Lensar Inc   0.83 $ 57.704  Millions$ 69.568  Millions
Masimo Corp  0.82 $ 1,557.000  Millions$ 1,890.425  Millions
Carlisle Companies Incorporated  0.82 $ 4,976.200  Millions$ 6,057.175  Millions
Rigel Pharmaceuticals Inc  0.82 $ 299.767  Millions$ 366.868  Millions
Penumbra Inc  0.81 $ 1,454.283  Millions$ 1,786.034  Millions
Alpha Pro Tech Ltd   0.81 $ 59.661  Millions$ 73.537  Millions
Incyte Corporation  0.81 $ 5,361.020  Millions$ 6,612.199  Millions
Airsculpt Technologies Inc   0.80 $ 151.836  Millions$ 190.897  Millions
Davita Inc   0.79 $ 13,835.088  Millions$ 17,507.080  Millions
Irhythm Holdings Inc   0.79 $ 787.387  Millions$ 996.413  Millions
Lifeward ltd   0.79 $ 20.923  Millions$ 26.566  Millions
Cadre Holdings inc   0.79 $ 635.663  Millions$ 809.065  Millions
West Pharmaceutical Services Inc   0.78 $ 3,220.500  Millions$ 4,109.600  Millions
Concentra Group Holdings Parent Inc   0.78 $ 2,232.220  Millions$ 2,858.416  Millions
Cytosorbents Corporation  0.78 $ 34.844  Millions$ 44.621  Millions
Phathom Pharmaceuticals Inc   0.78 $ 204.892  Millions$ 263.695  Millions
Iradimed Corporation  0.78 $ 86.282  Millions$ 111.084  Millions
Labcorp Holdings Inc   0.77 $ 14,144.200  Millions$ 18,450.325  Millions
Acadia Pharmaceuticals Inc   0.77 $ 1,095.250  Millions$ 1,431.438  Millions
Adapthealth Corp   0.75 $ 3,286.774  Millions$ 4,368.733  Millions
Msa Safety Inc  0.75 $ 1,917.299  Millions$ 2,555.537  Millions
Vivos Therapeutics Inc   0.75 $ 19.092  Millions$ 25.468  Millions
Beone Medicines Ltd   0.75 $ 5,737.861  Millions$ 7,668.293  Millions
Harmony Biosciences Holdings inc   0.74 $ 899.247  Millions$ 1,214.920  Millions
Journey Medical Corp  0.73 $ 64.680  Millions$ 88.118  Millions
Biomerica Inc   0.73 $ 4.326  Millions$ 5.906  Millions
Gyre Therapeutics Inc   0.73 $ 117.049  Millions$ 160.044  Millions
Delcath Systems Inc   0.73 $ 89.081  Millions$ 122.410  Millions



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.